Oligodendroglioma Pipeline Products / Drug Profiles Reviewed in H2 2015 Report

Nov 16, 2015, 03:00 ET from RnR Market Research

PUNE, India, November 16, 2015 /PRNewswire/ --

RnRMarketResearch.com adds Oligodendroglioma - Pipeline Review, H2 2015 market research report that reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and key players involved in the therapeutics development for Oligodendroglioma and enlists all their major and minor projects.

Complete report on oligodendroglioma spread across 141 pages, discussing 14 companies, 20 drug profiles and supported with 29 tables and 14 figures is now available at http://www.rnrmarketresearch.com/oligodendroglioma-pipeline-review-h2-2015-market-report.html .

This report provides comprehensive information on the therapeutic development for Oligodendroglioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Oligodendroglioma and special features on late-stage and discontinued projects.

Companies discussed in this report includes Axelar AB, Boehringer Ingelheim GmbH, Cavion LLC, Celgene Corporation, Celldex Therapeutics, Inc., e-Therapeutics Plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Millennium Pharmaceuticals, Inc., Novartis AG, Oncolytics Biotech Inc., Pfizer Inc., Sanofi and Tocagen Inc. Drug Profiles mentioned in this report are afatinib dimaleate, alisertib, AXL-1717, bevacizumab, CC-122, CDX-1401, Dendritic Cell Therapy for Gliomas, Dendritic Cell Therapy for Oncology, DNX-2401, ETS-2101, galunisertib, mibefradil dihydrochloride, nilotinib, palbociclib, panobinostat, pelareorep, plerixafor, Stem Cell Therapy for Glioma, temsirolimus and vocimagene amiretrorepvec + flucytosine ER.

Order a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=427342 .

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Oligodendroglioma summarizing all the dormant and discontinued pipeline projects. A review of the Oligodendroglioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Oligodendroglioma pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

List of Tables 

Number of Products under Development for Oligodendroglioma, H2 2015

Number of Products under Development for Oligodendroglioma - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Investigation by Universities/Institutes, H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Oligodendroglioma Therapeutics - Recent Pipeline Updates, H2 2015

Oligodendroglioma - Dormant Projects, H2 2015

Explore more reports on Cancer Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/cancer-therapeutics .

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research